A major role of TGF-β1 in the homing capacities of murine hematopoietic stem cell/progenitors

Blood

Volumn 116, Issue 8, 2010, Pages 1244-1253

  Capron, Claude ^a,b,c   Lacout, Catherine ^a   Lécluse, Yann ^a   Jalbert, Valérie ^c   Chagraoui, Hédia ^a   Charrier, Sabine ^a,d   Galy, Anne ^a,d   Bennaceur Griscelli, Annelise ^e   Cramer Bordé, Elisabeth ^b,c   Vainchenker, William ^a,d  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Hôpital Cochin ^*  (France)

^c Fac de Med Paris Ouest   (France)

^d GÉNÉTHON   (France)

^e HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW CELL; CELL DEATH; CELL HOMING; CELL SELECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; INFLAMMATORY DISEASE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION PROTECTION; REGULATORY T LYMPHOCYTE;

EID: 77956505670     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-05-221093     Document Type: Article

References (49)

1. Fortunel NO, Hatzfeld A, Hatzfeld JA. Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis. Blood. 2000;96(6):2022- 2036.
2. Marshall CJ, Kinnon C, Thrasher AJ. Polarized expression of bone morphogenetic protein-4 in the human aorta-gonad-mesonephros region. Blood. 2000;96(4):1591-1593. (Pubitemid 30658497)
3. Johansson BM, Wiles MV. Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development. Mol Cell Biol. 1995;15(1):141-151.
4. Bhatia M, Bonnet D, Wu D, et al. Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J Exp Med. 1999;189(7):1139-1148.
5. Keller JR, McNiece IK, Sill KT, et al. Transforming growth factor beta directly regulates primitive murine hematopoietic cell proliferation. Blood. 1990;75(3):596-602.
6. Ohta M, Greenberger JS, Anklesaria P, Bassols A, Massague J. Two forms of transforming growth factor-beta distinguished by multipotential haematopoietic progenitor cells. Nature. 1987;329(6139):539-541. (Pubitemid 17124773)
7. Cashman J, Clark-Lewis I, Eaves A, Eaves C. Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice. Blood. 2002;99(3):792-799. (Pubitemid 34525537)
8. Heinrich MC, Dooley DC, Keeble WW. Transforming growth factor beta 1 inhibits expression of the gene products for steel factor and its receptor (c-kit). Blood. 1995;85(7):1769-1780.
9. Pierelli L, Marone M, Bonanno G, et al. Modulation of bcl-2 and p27 in human primitive proliferating hematopoietic progenitors by autocrine TGF-beta1 is a cell cycle-independent effect and influences their hematopoietic potential. Blood. 2000;95(10):3001-3009.
10. Scandura JM, Boccuni P, Massague J, Nimer SD. Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc Natl Acad Sci U S A. 2004;101(42):15231-15236. (Pubitemid 39391747)
11. Ducos K, Panterne B, Fortunel N, Hatzfeld A, Monier MN, Hatzfeld J. p21(cip1) mRNA is controlled by endogenous transforming growth factor-beta1 in quiescent human hematopoietic stem/progenitor cells. J Cell Physiol. 2000;184(1):80-85. (Pubitemid 30349630)
12. Ewen ME, Sluss HK, Whitehouse LL, Livingston DM. TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell. 1993;74(6):1009-1020.
13. Karlsson G, Blank U, Moody JL, et al. Smad4 is critical for self-renewal of hematopoietic stem cells. J Exp Med. 2007;204(3):467-474. (Pubitemid 46457070)
14. Yamazaki S, Iwama A, Takayanagi S, Eto K, Ema H, Nakauchi H. TGF-beta as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation. Blood. 2009;113(6):1250-1256.
15. Hatzfeld J, Li ML, Brown EL, et al. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides. J Exp Med. 1991;174(4):925-929.
16. Ploemacher RE, van Soest PL, Boudewijn A. Autocrine transforming growth factor beta 1 blocks colony formation and progenitor cell generation by hemopoietic stem cells stimulated with steel factor. Stem Cells. 1993;11(4):336-347. (Pubitemid 23216734)
17. Larsson J, Goumans MJ, Sjostrand LJ, et al. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J. 2001;20(7):1663-1673. (Pubitemid 32299403)
18. Kallapur S, Ormsby I, Doetschman T. Strain dependency of TGFbeta1 function during embryogenesis. Mol Reprod Dev. 1999;52(4):341-349. (Pubitemid 29122259)
19. Bonyadi M, Rusholme SA, Cousins FM, et al. Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice. Nat Genet. 1997;15(2):207-211. (Pubitemid 27061646)
20. Kulkarni AB, Huh CG, Becker D, et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A. 1993;90(2):770-774. (Pubitemid 23028947)
21. Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factorbeta 1 gene results in multifocal inflammatory disease. Nature. 1992;359(6397):693-699.
22. Diebold RJ, Eis MJ, Yin M, et al. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc Natl Acad Sci U S A. 1995;92(26):12215-12219. (Pubitemid 26014041)
23. Kobayashi S, Yoshida K, Ward JM, et al. Beta 2-microglobulin-deficient background ameliorates lethal phenotype of the TGF-beta 1 null mouse. J Immunol. 1999;163(7):4013-4019. (Pubitemid 29450931)
24. Ghiringhelli F, Menard C, Terme M, et al. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med. 2005;202(8):1075-1085. (Pubitemid 41464501)
25. Larsson J, Blank U, Helgadottir H, et al. TGF-beta signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro. Blood. 2003;102(9):3129-3135. (Pubitemid 37314748)
26. Oh SP, Seki T, Goss KA, et al. Activin receptorlike kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A. 2000;97(6):2626-2631. (Pubitemid 30159221)
27. Lebrin F, Goumans MJ, Jonker L, et al. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J. 2004;23(20):4018-4028. (Pubitemid 39472423)
28. Chen CZ, Li M, de Graaf D, et al. Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells. Proc Natl Acad Sci U S A. 2002;99(24):15468-15473. (Pubitemid 35403957)
29. Perlingeiro RC. Endoglin is required for hemangioblast and early hematopoietic development. Development. 2007;134(16):3041-3048. (Pubitemid 47386915)
30. Langer JC, Henckaerts E, Orenstein J, Snoeck HW. Quantitative trait analysis reveals transforming growth factor-beta2 as a positive regulator of early hematopoietic progenitor and stem cell function. J Exp Med. 2004;199(1):5-14. (Pubitemid 38076473)
31. Chagraoui H, Komura E, Tulliez M, Giraudier S, Vainchenker W, Wendling F. Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice. Blood. 2002;100(10):3495-3503. (Pubitemid 35303916)
32. Capron C, Lecluse Y, Kaushik AL, et al. The SCL relative LYL-1 is required for fetal and adult hematopoietic stem cell function and B-cell differentiation. Blood. 2006;107(12):4678-4686. (Pubitemid 43882615)
33. Yilmaz OH, Kiel MJ, Morrison SJ. SLAM family markers are conserved among hematopoietic stem cells from old and reconstituted mice and markedly increase their purity. Blood. 2006;107(3):924-930.
34. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005;121(7):1109-1121. (Pubitemid 40884400)
35. Morrison SJ, Weissman IL. Heterogeneity of hematopoietic stem cells: implications for clinical applications. Proc Assoc Am Physicians. 1995;107(2):187-194.
36. Foudi A, Jarrier P, Zhang Y, et al. Reduced retention of radioprotective hematopoietic cells within the bone marrow microenvironment in CXCR4-/- chimeric mice. Blood. 2006;107(6):2243-2251. (Pubitemid 43345541)
37. Sinclair A, Daly B, Dzierzak E. The Ly-6E. 1 (Sca-1) gene requires a 3′ chromatin-dependent region for high-level gamma-interferon-induced hematopoietic cell expression. Blood. 1996;87(7):2750-2761.
38. Leveen P, Larsson J, Ehinger M, et al. Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood. 2002;100(2):560-568. (Pubitemid 34761120)
39. Basu S, Broxmeyer HE. Transforming growth factor-{beta}1 modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/CXCL12. Blood. 2005;106(2):485-493. (Pubitemid 40981242)
40. Franitza S, Kollet O, Brill A, et al. TGF-beta1 enhances SDF-1alpha-induced chemotaxis and homing of naive T cells by up-regulating CXCR4 expression and downstream cytoskeletal effector molecules. Eur J Immunol. 2002;32(1):193-202. (Pubitemid 34092837)
41. Christensen JL, Weissman IL. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci U S A. 2001;98(25):14541-14546.
42. Hsu HC, Ema H, Osawa M, Nakamura Y, Suda T, Nakauchi H. Hematopoietic stem cells express Tie-2 receptor in the murine fetal liver. Blood. 2000;96(12):3757-3762.
43. Na Nakorn T, Traver D, Weissman IL, Akashi K. Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J Clin Invest. 2002;109(12):1579-1585. (Pubitemid 34663520)
44. Christensen JL, Wright DE, Wagers AJ, Weissman IL. Circulation and chemotaxis of fetal hematopoietic stem cells. PLoS Biol. 2004;2(3):E75.
45. Alvarado-Sanchez B, Hernandez-Castro B, Portales-Perez D, et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun. 2006;27(2):110-118. (Pubitemid 44528260)
46. Dickson MC, Martin JS, Cousins FM, et al. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Specific binding of endocrine transforming growth factor-beta 1 to vascular endothelium. Development. 1995;121(6):1845-1854.
47. Oshima M, Oshima H, Taketo MM. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol. 1996;179(1):297-302. (Pubitemid 26363265)
48. Tang M, Wei X, Guo Y, et al. TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice. J Exp Med. 2008;205(7):1611-1619. (Pubitemid 351962025)
49. Dunn LK, Mohammad KS, Fournier PG, et al. Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment. PLoS ONE. 2009;4(9):e6896.